Top Challenges in Achieving DSCSA Interoperability

The Drug Supply Chain Security Act (DSCSA) was created to make sure that all medicines moving through the supply chain are safe, traceable, and not fake. To follow these rules, pharma wholesalers and others in the supply chain must share drug information in a secure and connected way.

But many pharma wholesalers face problems in meeting all DSCSA rules, especially when it comes to sharing and verifying drug data electronically. 

The Four Biggest Hurdles Pharma Wholesalers Face with DSCSA Rules

Here they are!

1. Securely Sharing TI and TS with Partners

Pharma wholesalers must send Transaction Information (TI) and Transaction Statements (TS) to their trading partners using safe and digital systems. 

This means everyone needs to use a common method and keep the data protected.

The problem is that not all companies use the same technology. Some partners still rely on older systems that don't match with new tools. This makes data sharing slow, difficult, or even risky in terms of security.

2. Sending Data for Each Drug Package

Earlier, wholesalers used to track drug lots or batches. Now, they must share information for each individual package of medicine. This package-level tracing is a big jump.

It means pharma wholesalers need better scanning tools, faster systems, and more storage for data. They also need to make sure each package is properly labeled and recorded. This upgrade takes time, effort, and money.

3. Verifying Product Details on Request

If a trading partner asks, wholesalers must be able to check and confirm the product identifier on a package. This code proves the drug is real.

But many pharma wholesalers do not have the right tools to scan and verify packages quickly. They might struggle to connect their systems to national databases or to handle urgent verification requests. 

This makes things slower and riskier, especially during recalls or investigations.

4. Providing Information Quickly When Asked

Sometimes, a regulatory body or partner might ask for TI and TS information for a particular drug. When this happens, pharma wholesalers must provide it fast.

However, pulling this data from different systems or teams can be a challenge. If the information is not organized well or stored in one place, delays can happen. These delays can lead to trouble with audits, investigations, or DSCSA compliance.

Moving Forward with Confidence

Drugzone understands how complex DSCSA rules can be, especially for pharma wholesalers. That’s why we are committed to offering compliant and reliable supply chain support. 

Whether it’s managing traceability, securing product data, or working with tech tools, Drugzone helps you stay ready for full DSCSA interoperability, without the stress.

Frequently Asked Questions (FAQs)

Q. What is DSCSA and why is it important?

The Drug Supply Chain Security Act (DSCSA) is a U.S. law that helps track and trace prescription drugs through the supply chain. It aims to prevent fake medicines and ensure patient safety.

Q. What are the main challenges in DSCSA compliance for pharma wholesalers?

Pharma wholesalers face issues like connecting different software systems, sharing data securely, and managing partner expectations. Meeting all rules and deadlines can also be tough.

Q. How can pharma wholesalers start preparing for DSCSA interoperability?

They should choose the right technology partners, train their staff, and work closely with suppliers and buyers. Starting early helps reduce errors and avoid compliance risks.

Article Author

Steve Thomas

Operations and Compliance

Working in Operations and Compliance at Drugzone Pharmaceuticals Inc. ,I manage Regulatory Strategy, Operations Management, Business Strategy, and many more. I also have experience in Project management, budgeting, and team leadership.